Showing 1 - 8 results of 8 for search 'Radu O Minea', query time: 0.04s Refine Results
  1. 1
    A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice

    A Novel Venom-Derived Peptide for Brachytherapy of Glioblastoma: Preclinical Studies in Mice by Steve Swenson, Radu O. Minea, Cao Duc Tuan, Thu-Zan Thein, Thomas C. Chen, Francis S. Markland

    Published 2018-11-01
    Get full text
    Article
  2. 2
    NEO212, a Perillyl Alcohol-Temozolomide Conjugate, Triggers Macrophage Differentiation of Acute Myeloid Leukemia Cells and Blocks Their Tumorigenicity

    NEO212, a Perillyl Alcohol-Temozolomide Conjugate, Triggers Macrophage Differentiation of Acute Myeloid Leukemia Cells and Blocks Their Tumorigenicity by Thomas C. Chen, Radu O. Minea, Steve Swenson, Zhuoyue Yang, Thu Zan Thein, Axel H. Schönthal

    Published 2022-12-01
    Get full text
    Article
  3. 3
    Rare Stochastic Expression of O6-Methylguanine- DNA Methyltransferase (MGMT) in MGMT-Negative Melanoma Cells Determines Immediate Emergence of Drug-Resistant Populations upon Treatment with Temozolomide In Vitro and In Vivo

    Rare Stochastic Expression of O6-Methylguanine- DNA Methyltransferase (MGMT) in MGMT-Negative Melanoma Cells Determines Immediate Emergence of Drug-Resistant Populations upon Treat... by Thomas C. Chen, Nymph Chan, Radu O. Minea, Hannah Hartman, Florence M. Hofman, Axel H. Schönthal

    Published 2018-09-01
    Get full text
    Article
  4. 4
    Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities.

    Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities. by Radu O Minea, Corey M Helchowski, Samuel J Zidovetzki, Fritz K Costa, Stephen D Swenson, Francis S Markland

    Published 2010-06-01
    Get full text
    Article
  5. 5
    Activation of Epstein–Barr Virus’ Lytic Cycle in Nasopharyngeal Carcinoma Cells by NEO212, a Conjugate of Perillyl Alcohol and Temozolomide

    Activation of Epstein–Barr Virus’ Lytic Cycle in Nasopharyngeal Carcinoma Cells by NEO212, a Conjugate of Perillyl Alcohol and Temozolomide by Hannah Hartman-Houstman, Steve Swenson, Radu O. Minea, Uttam K. Sinha, Ming-Fu Chiang, Thomas C. Chen, Axel H. Schönthal

    Published 2024-02-01
    Get full text
    Article
  6. 6
    Cytotoxic impact of a perillyl alcohol–temozolomide conjugate, NEO212, on cutaneous T-cell lymphoma

    Cytotoxic impact of a perillyl alcohol–temozolomide conjugate, NEO212, on cutaneous T-cell lymphoma by Catalina Silva-Hirschberg, Hannah Hartman, Samantha Stack, Steve Swenson, Radu O. Minea, Michael A. Davitz, Thomas C. Chen, Axel H. Schönthal

    Published 2019-12-01
    Get full text
    Article
  7. 7
    Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid Leukemia

    Potentially Curative Therapeutic Activity of NEO212, a Perillyl Alcohol-Temozolomide Conjugate, in Preclinical Cytarabine-Resistant Models of Acute Myeloid Leukemia by Axel H. Schönthal, Steve Swenson, Radu O. Minea, Hye Na Kim, Heeyeon Cho, Nazleen Mohseni, Yong-Mi Kim, Thomas C. Chen

    Published 2021-07-01
    Get full text
    Article
  8. 8
    Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas.

    Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas. by Radu O Minea, Tuan Cao Duc, Stephen D Swenson, Hee-Yeon Cho, Mickey Huang, Hannah Hartman, Florence M Hofman, Axel H Schönthal, Thomas C Chen

    Published 2020-01-01
    Get full text
    Article

Search Tools: